Skip to content

Endoscopic Ultrasound-guided Drainage of Walled Off Necrosis (WON)

Endoscopic Ultrasound-guided Drainage of Walled Off Necrosis (WON)

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03027895
Enrollment
256
Registered
2017-01-23
Start date
2018-09-30
Completion date
2020-09-30
Last updated
2018-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic Pseudocyst

Brief summary

The purpose of this study is to compare the effect of lumen-apposing metal stent (LAMS) and double pigtail plastic stents (DPPSs) on the drainage of pancreatic walled-off necrosis (WON), mainly to observe the efficacy and safety of LAMS for WON.

Detailed description

Patient with pancreatic walled-off necrosis (WON) would be treated randomized with lumen-apposing metal stent (LAMS) or double pigtail plastic stents (DPPSs) under the guidance of Endoscopic Ultrasonography. The investigators compare the effect of the two stents, including technical success, clinical success, adverse event, recurrence, and so on.

Interventions

DEVICELumen-apposing metal stent (LAMS)

Endoscopic Ultrasound-guided Drainage of WON with LAMS

DEVICEDouble pigtail plastic stent (DPPS)

Endoscopic Ultrasound-guided Drainage of WON with DPPS

Sponsors

Yiqi Du
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Subject with ages from 18-80 years old 2. Subject with pancreatic pseudocysts confirmed by CT 3. Subject with a history of MSAP or SAP, the pseudocysts were formed more than 3 months 4. The size of pseudocyst is more than 6 cm, and the cyst adjacent to the gastric wall 5. Subject has the symptoms related with the pseudocyst 6. The consent form has been signed

Exclusion criteria

1. Subject is younger than 18 years or older than 80 years 2. Pancreatic pseudocyst communicate with the main pancreatic duct 3. Subject can't accept the endoscopic procedure 4. Pancreatic pseudocyst with infection or subject diagnosed with pancreatic abscess 5. The distance between gastric and the wall of the pseudocyst is more than 1 cm 6. Subject with 2 or more than 2 cysts 7. Subject has blood coagulation dysfunction 8. Pregnant or subject has mental disorders

Design outcomes

Primary

MeasureTime frameDescription
clinical successuo to 1 monthsThe cysts completely disappeared, or diameter ≤ 2cm in the imaging follow-up symptoms have eased

Secondary

MeasureTime frameDescription
adverse eventup to 2months/ stent removeany adverse event occured after stent inserted
recurrence rateup to 12 monthsAfter the clinical success, imaging examination show cyst again and accompanied by symptoms
technical successup to 48 hoursStent placed through the wall bracket and pancreatic pseudocyst successfully

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 5, 2026